Cargando…
Differential expression of microRNA in the lungs of rats with pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a chronic disorder of the small pulmonary arteries, and the efficacy of the therapies and the prognosis remain poor. The pathobiology of PAH is complex, and needs to be elucidated by multiple approaches. The present study used a monocrotaline-induced PAH rat...
Autores principales: | Xiao, Tingting, Xie, Lijian, Huang, Min, Shen, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364860/ https://www.ncbi.nlm.nih.gov/pubmed/28000863 http://dx.doi.org/10.3892/mmr.2016.6043 |
Ejemplares similares
-
MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment
por: Wołowiec, Łukasz, et al.
Publicado: (2023) -
MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
por: Carregal-Romero, Susana, et al.
Publicado: (2020) -
New hope for a microRNA therapy for pulmonary arterial hypertension
por: Mehta, Jyoti, et al.
Publicado: (2013) -
Comparative transcription profiling of mRNA and lncRNA in pulmonary arterial hypertension after C75 treatment
por: Hou, Cuilan, et al.
Publicado: (2023) -
Inhibition of microRNA-30a alleviates vascular remodeling in pulmonary arterial hypertension
por: Ma, Wenrui, et al.
Publicado: (2021)